Fig. 1

Changes in AR-VAS Scores With MP-AzeFlu Treatment. Time course of mean (SEM) VAS scores of AR symptoms from day 0 to the last trial day (a) in the total study population and (b) stratified by the presence of comorbid asthma. AR, allergic rhinitis; SD, standard deviation; SEM, standard error of the mean; VAS, visual analog scale